BCM
AHCO icon

Bluefin Capital Management’s AdaptHealth AHCO Stock Holding History

Bluefin Capital Management’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-127,500
Closed -$1.3M – 606
2019
Q3 		$1.3M Buy
+127,500
New +$1.3M 0.19% 91

Other funds holding AHCO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
MAM
Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bluefin Capital Management's AHCO Position: Q4 2019 in Review

Bluefin Capital Management sold out of AdaptHealth (AHCO) in Q4 2019, closing a stake of 127,500 shares — an estimated $1.3M sold.

Bluefin Capital Management first reported a position in AHCO in Q3 2019 and held it in 1 quarter. The position peaked at $1.3M in Q3 2019. 23 funds tracked by Wall St. Rank hold AHCO as of Q4 2019.

  • Bluefin Capital Management reported no remaining AdaptHealth position as of Q4 2019 after selling out during the quarter.
  • Bluefin Capital Management sold 127,500 AdaptHealth shares in Q4 2019, an estimated $1.3M.
  • Bluefin Capital Management first reported a position in AdaptHealth in Q3 2019 and held it in 1 quarter.
  • Bluefin Capital Management's AdaptHealth position peaked at $1.3M in Q3 2019.
  • 23 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2019.

Based on Bluefin Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.